gamma-knife-treatment

GAMMAKNIFE PERFEXION for the Treatment of Brain Tumors GammaKnife is superior to other techniques because:

  • It is more precise
    Its technological features give it a precision of 0.3 mm.
  • It is more effective
    Its efficacy has been proven through thousands of published scientific articles.
  • Scientific studies confirm that it obtains the best result without harming the patient.
    Almost 3,000 medical journal articles have been published about GammaKnife to date.
  • It is used in a large number of centers.
    GammaKnife is currently being used in about 300 centers around the world.
  • It has proven itself since 1968.
    It is a radiosurgical technique that has been widely used for a long time.
    • What is GammaKnife?
      GammaKnife, a radiosurgery technique, was first used in 1968. In the beginning, it was employed in very few centers around the world, but as its therapeutic benefits were confirmed, its sphere of use widened. Today, GammaKnife is being used in about 300 centers around the world. According to statistics from 2012, approximately 600,000 patients with a variety of brain diseases have been treated with GammaKnife. There is no other device in this field that can approach the precision of GammaKnife and has helped this many people.

      Other techniques report their efficacy by comparing themselves with Gamma Knife. Gamma Knife is viewed as the gold standard of radiosurgery.

      brain-mr

      THE GAMMA KNIFE DIFFERENCE IN TREATMENT OF BRAIN TUMORS

      The advanced technology GammaKnife procedure makes it possible to treat brain tumors in a bloodless and painless fashion without open surgery so that the patient can return home the same day.
      The term radiosurgery was introduced to the world of medicine by the Swiss brain surgeon Lars Leksell and refers to the process of directing numerous low-energy radioactive beams that do not damage brain tissue to the diseased area in the skull and alter the tissue by focusing on the diseased spot and releasing a strong dose of radiation only at this spot.gamma-knife-team

  • GammaKnife Perfexion, the new state-of-the-art model from GammaKnife, which is characterized as the gold standard in Radiosurgery, shortens the treatment process for brain tumors painlessly and without open surgery, offering the patient convenience and comfort. Its advanced computer program helps specialists in treatment planning.
    • How is it administered?
      The GammaKnife procedure basically involves identifying the diseased area in the skull which is stabilized with a stereotactic frame and directing gamma rays from 192 cobalt sources at this area. Low-energy beams of radiation from multiple sources deliver a strong dose of radiation to the points where radiation is aimed without damaging the healthy portion of the brain.
    • Which diseases is it used for?
      GammaKnife is used on AVM (congenital arteriovenous malformation in the brain), brain tumors and functional diseases. In order to use GammaKnife, the tumor that will be treated must generally be smaller than 3.5 cm in diameter. GammaKnife eliminates the need for anesthesia and intensive care and takes only a few hours, providing patients with a treatment option that does not involve surgery. Most patients are able to return to their normal lives the day after treatment.
    • Why is GammaKnife preferred?
      Today, people want to resolve their health problems with simpler procedures and extensive medical research is being conducted to achieve this. GammaKnife radiosurgery meets this need because it is a technique that does not require the opening of the skull.
    • How Does GammaKnife Work?
      Stereotactic radiosurgery affects tissue like other radiotherapy techniques. With GammaKnife the tumor or diseased tissue is not removed. Instead, the DNA of the cells is impaired, and as a result the tumor cells lose their normal functions and die because they are unable to divide and receive nourishment. The rate of tumor shrinkage is approximately equivalent to the rate of growth. In patients who have congenital abnormal tangle of blood vessels, also known as AVM, GammaKnife causes the blood vessel walls to thicken and eventually clog up. The goal in treatment is to stop the growth of the tumor. If the tumor does not grow after treatment, this shows that the treatment was successful. Generally, the tumors shrink over time. However, the reduction in size may take years in benign tumors and months in malignant tumors and cases of metastasis. The obliteration of the AVM tangle of blood vessels occurs over a period of time, generally between 2-3 years.

    The advantages of GammaKnife treatment
    It can eliminate the need for open surgery on many brain tumors
    There few adverse effects following the procedure

  • gamma-knife-doctors
    • It does not require general anesthesia
      The patient can return to their home the day the treatment is performed
      There is no recovery period
      There is no incision on the scalp or head
      Hair does not have to be cut and does not fall out
      Tremendous benefit with little discomfort
      Ability to return to work quickly
      Less expensive than some surgical procedures
      Healthy brain tissue is exposed to very little radiation
    • Advantages of GammaKnife compared to surgery

      Symptoms / Diagnosis


      Open Surgery

      1-4 days of Intensive Care
      4-10 day hospital stay
      4-6 week recovery period
      Return to normal life

    Symptoms / Diagnosis
    GammaKnife
    Return to normal life

    • Areas in which GammaKnife Radiosurgery is used
      GammaKnife has been used around the world since 1968 on an increasingly large number of patients with various indications. GammaKnife is described as the “gold standard” in stereotactic radiosurgery. By 2012, almost 600,000 patients had been treated with it around the world. GammaKnife radiosurgery is used at the Acıbadem Health Group Kozyatağı Hospital for the following indications.
    • Patients with blood vessel conditions
      Arteriovenous malformation (AVM – congenital tangle of blood vessels in the brain)
      Cavernomas
    • Patients with benign tumors
      Vestibular schwannoma (tumor on the hearing and balance nerve)
      Hemangioblastoma
      Meningioma
      Chordoma
      Pituitary tumor
      Trigeminal schwannoma
      Tumors of the pineal region
      Craniopharyngioma
      Glomus jugulare tumor
    • Patients with malignant tumors
      Metastasis
      Uveal melanoma
      Certain glial tumors
      Hemangiopericytoma
      Nasopharyngeal carcinoma
    • Patients with movement disorders
      Tremors associated with Parkinson’s disease
      Essential tremors
    • Patients with functional disease
      Trigeminal neuralgia
    • Hard-to-reach tumors located deep in the brain
    • Patients unable to tolerate surgical procedures for reasons such as age, medical condition and general health status
    • Patients who refuse open surgery